跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG - HSA Drug Approval Details
Approvals
/
HSA
/
PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG
Approved
THERAPEUTIC
PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG
DR.REDDY'S LABORATORIES LTD (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Sep 23, 2019
Approval ID
b4f44526963f6381
Company
DR.REDDY'S LABORATORIES LTD (INDIA)
Type
Therapeutic
Approval Details
Approval Id
b4f44526963f6381
Drug Name
PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG
Product Name
PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG
Approval Number
SIN15817P
Approval Date
2019-09-23
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
PARENTERAL
Atc Code
L01BA04
Atc Item Name
pemetrexed
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Pemetrexed disodium(Amorphous) 551.4 mg eqv to Pemetrexed
500 mg
PEMETREXED DISODIUM (AMORPHOUS) 551.4 MG EQV TO PEMETREXED
500 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 23, 2019
Approval ID
b4f44526963f6381
Type
Therapeutic
Back to HSA Approvals